ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITOR (ARNI) HAS MORE EFFECTS IN REDUCING ALDOSTERONE CONCENTRATIONS AND CARDIAC HYPERTROPHY IN WELL-CONTROLLED HYPERTENSIVE PATIENTS

被引：0
|
作者：
Satoh, Fumitoshi [1 ,2 ]
Tezuka, Yuta [1 ,2 ]
Omata, Kei [1 ,2 ]
Ono, Yoshikiyo [1 ,2 ]
Morimoto, Ryo [2 ]
Ito, Sadayoshi [2 ]
Tanaka, Tetsuhiro [2 ]
机构：
[1] Tohoku Univ, Grad Sch Med, Div Clin Hypertens Endocrinol & Metab, Sendai, Miyagi, Japan
[2] Tohoku Univ Hosp, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi, Japan
来源：
JOURNAL OF HYPERTENSION | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
PS-C22-9
引用
收藏
页码：E403 / E403
页数：1
相关论文
共 30 条
  • [21] Combined effects of sodium-glucose cotransporter 2 inhibitor and angiotensin receptor-neprilysin inhibitor on renal function in cardiovascular disease patients with type 2 diabetes mellitus: a retrospective cohort study
    Xu, Ling
    Chen, Bo
    Zhang, Hua
    Zhu, Dan
    FRONTIERS IN ENDOCRINOLOGY, 2024, 14
  • [22] Effects of the angiotensin receptor antagonist candesartan and the ACE inhibitor enalapril on ultrasound markers of myocardial fibrosis in hypertensive patients with left ventricular hypertrophy
    Ciulla, MM
    Pallotti, R
    Esposito, A
    Cuspidi, C
    Muiesan, ML
    Salvetti, M
    Agabiti-Rosei, E
    Magrini, F
    Zanchetti, A
    JOURNAL OF HYPERTENSION, 2005, 23 : S381 - S381
  • [23] Respective effects of OSA treatment and angiotensin receptor blocker on aldosterone in hypertensive OSA patients: A randomized cross-over controlled trial
    Lacedonia, D.
    Tamisier, R.
    Roche, F.
    Monneret, D.
    Baguet, J. P.
    Levy, P.
    Pepin, J. L.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 177 (02) : 629 - 631
  • [24] Combined Therapy of Low-Dose Angiotensin Receptor-Neprilysin Inhibitor and Sodium-Glucose Cotransporter-2 Inhibitor Prevents Doxorubicin-Induced Cardiac Dysfunction in Rodent Model with Minimal Adverse Effects
    Kim, Donghyun
    Jang, Gyuho
    Hwang, Jaetaek
    Wei, Xiaofan
    Kim, Hyunsoo
    Son, Jinbae
    Rhee, Sang-Jae
    Yun, Kyeong-Ho
    Oh, Seok-Kyu
    Oh, Chang-Myung
    Park, Raekil
    PHARMACEUTICS, 2022, 14 (12)
  • [25] Comparison of anti hypertensive effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist and a diuretic in patients with hypertension not controlled by angiotensin receptor blocker monotherapy
    Stergiou, GS
    Makris, T
    Papavasiliou, M
    Efstathiou, S
    Manolis, A
    JOURNAL OF HYPERTENSION, 2005, 23 (04) : 883 - 889
  • [26] Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy
    Kohno, M
    Yokokawa, K
    Yasunari, K
    Kano, H
    Minami, M
    Hanehira, T
    Yoshikawa, J
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1997, 35 (01) : 38 - 42
  • [27] Comparative effects of ACE inhibitor perindopril and angiotensin II receptor antagonist valsartan on the left ventricular hypertrophy and diastolic function in hypertensive type 2 diabetic patients
    Vatinian, S
    Gurgenyan, SV
    Nikogosyan, KG
    Mamikonyan, AA
    EUROPEAN HEART JOURNAL, 2004, 25 : 210 - 210
  • [28] Comparative Effects of Direct Renin Inhibitor and Angiotensin Receptor Blocker on Albuminuria in Hypertensive Patients with Type 2 Diabetes. A Randomized Controlled Trial
    Uzu, Takashi
    Araki, Shin-ichi
    Kashiwagi, Atsunori
    Haneda, Masakazu
    Koya, Daisuke
    Yokoyama, Hiroki
    Kida, Yasuo
    Ikebuchi, Motoyoshi
    Nakamura, Takaaki
    Nishimura, Masataka
    Takahara, Noriko
    Obata, Toshiyuki
    Omichi, Nobuyuki
    Sakamoto, Katsuhiko
    Shingu, Ryosuke
    Taki, Hideki
    Nagai, Yoshio
    Tokuda, Hiroaki
    Kitada, Munehiro
    Misawa, Miwa
    Nishiyama, Akira
    Kobori, Hiroyuki
    Maegawa, Hiroshi
    PLOS ONE, 2016, 11 (12):
  • [29] Effects of antihypertensive treatment on ultrasound measures of myocardial fibrosis in hypertensive patients with left ventricular hypertrophy: results of a randomized trial comparing the angiotensin receptor antagonist, candesartan and the angiotensin-converting enzyme inhibitor, enalapril
    Ciulla, Michele M.
    Paliotti, Roberta
    Esposito, Arturo
    Cuspidi, Cesare
    Muiesan, M. Lorenza
    Rosei, Enrico Agabiti
    Magrini, Fabio
    Zanchetti, Alberto
    JOURNAL OF HYPERTENSION, 2009, 27 (03) : 626 - 632
  • [30] Antihypertensive and cardiovascular effects of combined blockade of renin-angiotensin system with ACE inhibitor and angiotensin II type 1 receptor blocker in hypertensive patients: A 24-week randomized controlled double-dummy trial
    Argano, Christiano
    Scaglione, Rosario
    Di Chiara, Tiziana
    Colomba, Daniela
    Parrinello, Gaspare
    Corrao, Salvatore
    Licata, Giuseppe
    HEART INTERNATIONAL, 2006, 2 (01): : 39 - 48
123